ZVS203e
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ZVS203e, covering 2025-05-01 to 2025-05-01. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of ZVS203e in the Treatment of Retinitis Pigmentosa Caused by RHO Gene Mutation [Phase 1, Phase 2]